Related Experiment Video
Updated: Sep 20, 2025

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.3K
Glypican-3 as a Radiotheranostic Target for Neuroendocrine Prostate Cancer
Woonghee Lee1, Joon-Yong Chung1, Kwamena E Baidoo1
1Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
European Urology
|May 22, 2025
Abstract
No abstract available in PubMed .

